Skip to main content

AEON Biopharma, Inc.

AEON
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001837607

In the last 90 days, AEON Biopharma, Inc. insiders filed 3 open-market purchases and 0 sales; 28 institutions reported holding it in 13F filings for Q3 2026, worth $18.7M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by AEON Biopharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
3 filings
3 insiders, $57.1K in total
Open-market sells
0 filings
Insiders trading
3
Net value
+$57.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for AEON Biopharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for AEON Biopharma, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Wilson Alexander BlairCLO, CSO and Corp Secretary2,318,711Nov 20, 20262
Sy JenniferChief Accounting Officer1,655,022Nov 20, 20262
Bancroft Robert E.President and CEO3,329,436Nov 20, 20262
Daewoong Co., Ltd10% Owner23,184,523IndirectNov 10, 20261
Lynch Timothy P10% Owner6,500,000Aug 21, 20261
Palmisano Robert JDirector258,705Jun 22, 20261
Thunen Shelley BDirector258,705Jun 22, 20261
Fischer JostDirector489,469Jun 22, 20261
Carter Eric GDirector258,705Jun 22, 20261
Forth MarcDirector973,231Jun 22, 20261
Bencich JohnCHIEF FINANCIAL OFFICER754,717Apr 3, 20261
Oh ChadCHIEF MEDICAL OFFICER2,183,436Mar 11, 20261
Strathspey Crown Holdings Group, LLC10% Owner2,031,773Aug 14, 20230
Malik Vikram10% Owner6,989,163IndirectJul 26, 20230
Priveterra Sponsor, LLC10% Owner6,989,163IndirectJul 26, 20230
Grodnensky Oleg10% Owner6,989,163IndirectJul 26, 20230
Barclays PLC10% Owner–Mar 31, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 20, 2026 (view filing)5:11 PM ETNov 20Same dayWilson Alexander BlairCLO, CSO and Corp SecretaryPPurchaseClass A Common Stock+135.7K$0.1288+$17.5K+6.2%2.32M after
Nov 20, 2026 (view filing)5:10 PM ETNov 191 daySy JenniferChief Accounting OfficerPPurchaseClass A Common Stock+153.8K$0.1299+$20.0K+10.2%1.66M after
Nov 20, 2026 (view filing)5:08 PM ETNov 191 dayBancroft Robert E.President and CEOPPurchaseClass A Common Stock+152.3K$0.1286+$19.6K+4.8%3.33M after
Aug 21, 2026 (view filing)7:41 PM ETAug 192 daysLynch Timothy P10% OwnerPPurchaseClass A Common Stock+1.15M$0.2117+$243.5K+21.5%6.50M after
May 23, 2025 (view filing)4:46 PM ETMay 212 daysFischer JostDirectorPPurchaseClass A Common Stock+60.0K$0.4875+$29.3K+29.0%266.8K after
May 21, 2025 (view filing)May 19-202 daysFischer JostDirectorPPurchaseClass A Common Stock+110.0K$0.5055+$55.6K+113.7%206.8K after2 lots
Aug 14, 2023 (view filing)Aug 113 daysStrathspey Crown Holdings Group, LLC10% OwnerSSaleClass A Common Stock−7.38M$10.00−$73.8M−78.4%2.03M after